To investigate the pathogenicities of P. pneumotropica (Pp) and V-factor dependent Pasteurellaceae (VFDP) in immunodeficient rats, experimental infections of F344-rnu rats were performed using 3 strains (ATCC 35149, CNP 160 and RPZ) 
Introduction
The family Pasteurellaceae includes both pathogenic and non-pathogenic species for many animals. The family consists of thirteen genera including Actinobacillus, Haemophilus, and Pasteurella that have previously been reported in isolates from rodents [1, 5, 13, 14] . In the past, two Pasteurellaceae, Pasteurella pneumotropica and taxonomically unclassified V-factor dependent Pasteurellaceae (VFDP), have been reported as associative agents for some lesions in laboratory rats [2, 3, 7, 12, 15, 16] . In microbiologic monitoring of laboratory rats in Japan, P. pneumotropica is regarded as a routine test item based on previous reports concerning pathoge-nicity and high contamination rates [8] . On the other hand, VFDP is not regarded as a test item because of lack of information on its pathogenicity and prevalence in Japan.
Most of the previous reports of Pasteurellaceae infection in laboratory rats were cases of natural infection. A few experimental infection studies have been performed, but only for P. pneumotropica [4, 11] . Reports on P. pneumotropica, in particular, were published in the 1960s and 1970s [3, 4, 11, 12, 15] , and our present knowledge of the pathogenicity of P. pneumotropica in rats is based on them. However, some respiratory pathogens such as cilia-asociated respiratory (CAR) bacillus had not been discovered in the 1960s and '70s [6] , and it is difficult to accurately judge P. pneumotropica as pathogens from the early reports. In this study, we performed experimental infections with P. pneumotropica and VFDP in immunodeficient (F344-rnu) rats to obtain basic information on their pathogenicity in rats.
Materials and Methods
The animal experimental protocol was approved by the Institutional Animal Care and Use Committee based on the Regulations for Animal Experimentation of the Central Institute for Experimental Animals (Approval No. 06007). The Regulations were established in compliance with the Law for the Humane Treatment and Management of Animals.
Animals
Thirty-two 4-week-old female SPF F344/NJcl-rnu/rnu rats were obtained from a commercial vendor (CLEA Japan, Tokyo, Japan). The animals were housed in sterilized polycarbonate cages and kept in an isolation rack (FRP BIO2000, CLEA Japan) with ad libitium supply of sterilized commercial pellets (CA-1, CLEA Japan) and tap water. The animals were maintained at a room temperature of 23-25°C, relative humidity between 50 and 60%, and a light and dark cycle of 12 h each.
Health status
Vendor and in-house monitoring reports indicated that the animals were free of the following bacterial, viral and parasitic pathogens. 
Bacterial strains
Three strains of P. pneumotropica (ATCC 35149, CNP 160 and RPZ) and four strains of VFDP (V6, V7, V8 and V9) were used in this study. Strains ATCC 35149 and CNP 160 were obtained from the American Type Culture Collection (VA, USA) and the Collection Institute Pasteur (Paris, France), respectively. Both of them were originated from mice. The RPZ strain and VFDP strains were isolated from tracheal swabs of clinically healthy immunocompetent rats using 5% horse blood agar (HBA) or HBA supplemented with 10 µg of b-NAD (Wako Pure Chemical Industries, Osaka, Japan) per ml (HBANAD), and established in pure cultures. They were examined for some phenotypic traits (Gram-stain, oxidase, catalase, X and V-factor dependency), and then frozen at -80°C in a suspended condition in Brain Heart Infusion (BHI) broth (Difco Laboratories, Detroit, MI, USA) or BHI broth supplemented with 10 µg of b-NAD per ml (BHINAD broth) until the experiments were initiated. For this study, they were reisolated using HBA or HBANAD, characterized, and grown aerobically at 37°C for 24 h in BHI broth or BHINAD broth before inoculation of animals. Details of the characterization procedures were reported previously [8, 10] . Biochemical properties and V-factor dependency of all strains used in this study are summarized in Table 1 .
Experimental infection
Twenty-eight animals were divided into 7 groups for experimental infection (experimental groups). Two animals were grouped as a negative control with inoculation of PBS (NCPBS group), and one animal was used as a negative control with no treatment (NC). The experimental inoculations were performed twice on day 0 and post-inoculation day (PID) 14. The inoculation schedule was led by our pilot studies for good fixation of bacterial strains to animals. The animals were inoculated with 25 µl of bacterial suspensions adjusted to 10 7 CFU/ml with sterilized PBS, intranasally. The animals in the NCPBS group were inoculated with 25 µl of sterilized PBS with the same schedule as for the experimental groups. Two animals from each experimental group were sacrificed and examined on PID 60 and 120. One animal in the NCPBS group was also sacrificed and examined on PID 60 and 120. The NC animal was sacrificed and examined on PID 120. All inoculations of animals were performed under isoflurane anesthesia, and all sacrifices were performed by exsanguination from the axillary artery and vein under isoflurane anesthesia.
Isolation of bacterial strains
Isolation of bacterial strains was attempted using nasal swabs, tracheal swabs, blood from the heart, the right lobes of the lung, and one half of the spleen of the animals. The swab samples were streaked directly on the media, and 100 µl of blood was inoculated on the media. Lung and spleen were homogenized with 500 µl of sterilized PBS, and 100 µl samples inoculated on the media.
Histopathologic examination
Histopathological examinations on nasal cavity mucosa, trachea, left lobe of the lung and spleen were performed for all animals. Nasal concha, trachea, lung and one half of the spleen were fixed in 10% buffered formalin, and stained with hematoxylin and eosin using standard procedures. Nasal concha was decalicified with 5% formic acid prior to staining.
Results

Observation of general status and necropsy
Sneezing was observed in each animal in the experimental group inoculated with P. pneumotropica ATCC 
Isolation of bacterial strains
The results are shown in Table 2 . On PID 60, only strains of P. pneumotropica (ATCC 35149, CNP 160 and RPZ) were isolated from the nasal cavity. All the bacterial strains were isolated from the tracheas of two animals from each group except for strain V7 that was isolated from one animal. Strains ATCC 35149 and V7 were also isolated from the lungs of two animals. No bacterial strains were isolated from spleens and blood of any animal. On PID 120, strains ATCC 35149 and RPZ of P. pneumotropica were isolated from the nasal cavity of two animals. Five bacterial strains (ATCC 35149, RPZ, V7, V8 and V9) were isolated from the trachea of one (ATCC 35149 and V7) or two animals (RPZ, V8 and V9) from each group. These 5 strains were also isolated from the lungs of two animals from each group. CNP 160 and V6 strains were not isolated from any sites tested. No bacterial strains were isolated from spleens or blood of any animal.
Histopathologic examination
On PID 60, sloughing of the cilia of the nasal mucosal epithelium was observed in two animals from the ATCC 35149 group. Inflammation and necrosis of nasal mucosal epithelium were observed in all animals from the ATCC 35149 and CNP 160 groups (Table 2 and Fig.1) . No histopathological changes were observed in other regions of these animals or in any region of other animals. On PID 120, atrophy of the epithelium and inflammation of nasal mucosa were observed in two animals from the ATCC 35149 group. Edema of the nasal submucosa was observed in two animals from the CNP 160 group. No histopathological changes were observed in other regions or in any region of other animals including the animals from the NCPBS and NC groups. 
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Discussion
In the present study, all strains of P. pneumotropica but not VFDP were isolated from the nasal cavity. These findings were similar to those of two Pasteurellaceae natural infection cases reported by Nicklas [16] . Only two strains (ATCC 35149 and V7) were isolated from the lungs on PID 60, but the number increased from two to five strains (ATCC 35149, RPZ, V7, V8 and V9) on PID 120. Isolation of P. pneumotropica from the lungs of rats in cases of natural infection was reported to be rare [17] . In the present study, we used bacterial suspensions adjusted to 10 7 CFU/ ml for inoculation. Therefore, the discrepancies between the results of the previous report and our report seem to be caused by differences in the numbers of bacterial cells that invaded the animals in each study.
P. pneumotropica has been reported as an associative agent for clinical disorders of rats such as pneumonia, conjunctivitis and mastitis [3, 12, 15] . To clarify the pathogenicity in rats, some researchers have attempted to produce clinical disorders. Burek et al. inoculated P. pneumotropica into SD rats using a nebulizer to produce respiratory disease [4] . Hill inoculated it into the conjunctival sac of A/GUS rats to produce conjunctivitis [9] . Both attempts were unsuccessful. In our results, sneezing was observed in two animals and one animal inoculated with strains ATCC 315149 and CNP 160, respectively. This clinical sign seemed to be related to histopathological changes in the mucosa of the nasal cavity that were observed in animals from both groups ( Table 2) . No other evidence concerning the cause of the histopathological changes except bacterial inoculation was found. Therefore, it was strongly suggested that the changes were caused by strains ATCC 35149 and CNP 160. The histopathological changes in the animals inoculated with strain CNP 160 seemed to be caused before PID 60, because the strain was not isolated on PID 120. Bacterial isolates with no associated histopathological changes in tracheas and lungs were found in animals in both the ATCC 35149 and CNP 160 groups. Therefore, these strains seem not to be pathogenic in trachea and lungs of rats. In contrast to the animals inoculated with strains ATCC 35149 and CNP 160, no histopathological changes were observed in any 
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animal inoculated with strain RPZ, although bacteria were isolated from the respiratory tract. Recently, P. pneumotropica isolates were reported as genetically different by its host animal species [9, 18] . Although limited numbers of strains were used in this study, the pathogenicity of P. pneumotropica derived from rats may be extremely low in rats. A few natural infections have been reported that mentioned the pathogenicity of VFDP. Harr et al. reported bacteria suspected to be VFDP as an associative agent in acute and mortal respiratory disease of rats [7] . Nicklas [16] and Boot et al. [2] reported VFDP as an associative agent for histopathological changes in the lungs such as diffuse hyperemia and slight inflammatory cell infiltration. In the present study, no clinical signs or histopathological changes were observed in any animal inoculated with VDFP strains including the animals from which the bacterial strains were recovered ( Table 2) . Pathogenicity of VFDP for rats was not proved from the results. In an epidemiological study, we checked 1154 immunocompetent and immunodeficient rats in 70 colonies in Japan using tracheal swabs from June 2005 to August 2006, and found 20 rats in 15 colonies contaminated with VFDP, but no gross abnormalities related to VFDP were observed. In the survey, VFDP was also isolated from lungs without gross abnormalities. These findings were in agreement with the results of the present experimental study. These results suggest that VFDP is not pathogenic but is harbored as parasitic bacteria in the respiratory organs of laboratory rats.
In conclusion, P. pneumotropica strains ATCC 35149 and CNP 160 produced clinical symptoms and histopathological changes in immunodeficient rats, but P. pneumotropica strain RPZ did not produce symptoms or changes in any rat. The VFDP strains produced neither clinical symptoms nor histopathological changes in immunodeficient rats, even at high doses; therefore, they seem not to be pathogenic for rats. Our results should be useful as basic information for microbiological management of laboratory rats.
